Furthermore, DA showed that Osimertinib was not only significantly associated with Blood and lymphatic system disorders, Gastrointestinal disorders, and Renal and urinary disorders but was also the only EGFR-TKI to yield a positive signal for Cardiac disorders. This evidence concerns the gene EGFR and lymphatic system disorder.